• AML
  • Qui Tam
  • SEC
  • CFTC
  • FCPA
  • FAQS
Subscribe
Donate
No Result
View All Result
Whistleblower Network News
The Truth at Any Cost.
Qui Tam, Compliance and Anti-Corruption News.
Whistleblower Network News
No Result
View All Result
Home False Claims-Qui Tam

Bayer To Pay $40 Million to Resolve Kickback Allegations; Whistleblower Awarded $11 Million

Ana PopovichbyAna Popovich
September 7, 2022
in Corporate
Reading Time: 3 mins read
Photo of a Bayer building

Whippany, New Jersey, NY, USA - August 16, 2022: Bayer HealthCare U.S. headquarters in Whippany, New Jersey, August 16, 2022. Bayer AG is a German pharmaceutical company.

Share on TwitterShare on FacebookShare on LinkedInEmail

Pharmaceutical manufacturer Bayer Corporation and its related entities will pay $40 million to resolve allegations that it violated the False Claims Act. The case stemmed from two qui tam, or whistleblower, lawsuits filed by Laurie Simpson, a former Bayer employee. For her role as a whistleblower in the case, Simpson will receive $11 million.

Simpson first filed a qui tam complaint in the U.S. District Court for the District of New Jersey, according to the settlement agreement. She subsequently filed “nine amended complaints in the New Jersey Action, with the operative, Tenth Amended Complaint filed on April 14, 2015.” The 2015 complaint included claims brought on behalf of the U.S., 20 states, and the District of Columbia.

In the lawsuit filed in the District of New Jersey, “Simpson alleged that Bayer paid kickbacks to hospitals and physicians to induce them to utilize the drugs Trasylol and Avelox, and also marketed these drugs for off-label uses that were not reasonable and necessary,” according to the U.S. Department of Justice (DOJ) press release. The press release states that “Trasylol is a drug used to control bleeding in certain heart surgeries” and “Avelox is an antibiotic approved to treat certain strains of bacteria.”

Register for National Whistleblower Day

Simpson also alleged “that Bayer downplayed the safety risks of Trasylol.” The lawsuit alleged that because of this activity, “Bayer caused the submission of false claims to the Medicare and Medicaid Programs and violated the laws of 20 states and the District of Columbia.”

In a second lawsuit that was transferred to the District of Minnesota, Simpson alleged that Bayer “knew about, but downplayed” the dangers of Baycol, the company’s statin drug. Allegedly, the drug had risks of causing rhabdomyolysis. “The lawsuit further alleged that Bayer misrepresented the efficacy of Baycol when compared to other statins and fraudulently induced the Defense Logistics Agency to renew certain contracts relating to Baycol. Subsequently, Trasylol and Baycol were withdrawn from the market for safety reasons,” the press release states.

The qui tam provisions of the False Claims Act enable private citizens to file lawsuits on behalf of the government if they know of an individual or company defrauding the government. Qui tam whistleblowers are eligible to receive between 15 and 30% of the government’s recovery, if one occurs. In this case, the U.S. government intervened in the whistleblower’s case and conducted the investigation.

U.S. Attorney Philip R. Sellinger for the District of New Jersey said in the press release that Bayer “engaged in a series of unlawful acts, including paying kickbacks to doctors and hospitals, marketing them off-label, and downplaying their safety risks.”

Principal Deputy Assistant Attorney General Brian M. Boynton, head of the DOJ’s civil division, praised Simpson’s whistleblowing efforts, stating: “Simpson diligently pursued this matter for almost two decades…Today’s recovery highlights the critical role that whistleblowers play in the effective use of the False Claims Act to combat fraud in federal healthcare programs.”

The Importance of Healthcare Whistleblowers

Whistleblowers are key to uncovering corruption and misconduct in the healthcare industry: fraudulent schemes can be particularly harmful to patients and erode trust in the medical system. In Fiscal Year 2021, qui tam whistleblowers helped the DOJ recover $1.6 billion in settlements. The DOJ highlighted health care fraud as “the leading source of the department’s False Claims Act settlements and judgments.”

Read the DOJ press release here. 

Read the settlement agreement here. 

Read more false claims/qui tam news on WNN.

Tags: HealthHealth Care whistleblowerHealthcare
Previous Post

Russian National Sentenced for Involvement in Dumping Waste in U.S. Waters, Attempted Cover-Up

Next Post

CFTC Accepting Whistleblower Award Applications for New Jersey Fraud Case

Ana Popovich

Ana Popovich

Ana Popovich is a contributing editor with Whistleblower Network News, where she writes about breaking whistleblower news, healthcare fraud whistleblowers, and Covid-19 fraud whistleblowers. Ana has a B.A. in English from Georgetown University. While at Georgetown, she was the marketing chair of an affinity group and wrote content for the McDonough School of Business’ Business for Impact program. In 2018, Popovich was a public interest legal intern at the whistleblower law firm Kohn, Kohn and Colapinto. 

Next Post
New Jersey Whistleblower

CFTC Accepting Whistleblower Award Applications for New Jersey Fraud Case

Receive Daily Alerts

Subscribe to receive daily breaking news and legislative developments sent to your inbox.

  • This field is for validation purposes and should be left unchanged.

Most Popular

Calls Grow for Law Protecting AI Whistleblowers

Advocates Detail Need for SEC Whistleblower Reform

Raytheon Whistleblower Receives $1.5 Million for Alleging Cybersecurity Non-Compliance

Ruling Striking Down Trump Order Targeting Law Firm Seen as Crucial for Whistleblowers

MJH Healthcare Settles Whistleblower Allegations of Postal Rate Fraud for $2 Million

Poll Shows Overwhelming Support for Stronger Whistleblower Laws in Australia, Mirroring Polling in US

Whistleblower Poll

Whistleblower Poll
Whistleblower Poll

Exclusive Marist Poll: Overwhelming Public Support Among Likely Voters For Increased Whistleblower Protections

byGeoff Schweller
October 6, 2020

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

STAY INFORMED.
Subscribe to receive breaking whistleblower updates.

  • This field is for validation purposes and should be left unchanged.

About Us

  • About
  • Contact Us
  • Donate
  • Careers

Subscribe

  • Daily Mail
  • Follow us on Twitter
  • YouTube Channel

Contribute

  • Letter to the Editor
  • Submission Guidelines
  • Reprint Guidelines

Your Experience

  • Accessibility Statement
  • Privacy Policy
  • Terms of Use

Help

  • Rules for Whistleblowers
  • Frequently Asked Questions
  • Advertise
Whistleblower Network News

Whistleblower Network News is an independent online newspaper providing our readers with up-to-date information on whistleblowing. Our goal is to be the best source of information on important qui tam, anti-corruption, compliance, and whistleblower law developments. 

Submit an Article

Copyright © 2025, Whistleblower Network News. All Rights Reserved.

This Newspaper/Web Site is made available by the publisher for educational purposes only as well as to give you general information and a general understanding of the law, not to provide specific legal advice. By using this website, you understand that there is no attorney-client relationship between you and the Newspaper/Web Site publisher. The Newspaper/Web Site should not be used as a substitute for competent legal advice from a licensed professional attorney in your state.

Become a Whistleblower Network News Subscriber

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Subscribe to WNN

Retrieve your password

Please enter your username or email address to reset your password.

Subscribe to WNN
RSVP to National Whistleblower Day 2025! July 30, 2025 on Capitol Hill
RSVP NOW

Add New Playlist

No Result
View All Result
  • Exclusives
  • Government
    • False Claims-Qui Tam
    • Federal Employees
    • Intelligence
  • Corporate
    • CFTC & Commodities
    • Dodd-Frank
    • IRS & Tax
    • SEC & Securities
  • Features
  • Legislation
  • International
    • Foreign Corruption
  • Rewards
  • Whistleblower of the Week
  • Environment & Climate
  • Opinion
  • Editorial
  • Employment
    • Sarbanes-Oxley Whistleblowers
    • Retaliation
    • OSHA
  • Make National Whistleblower Day Permanent
  • Media
    • Podcasts
    • Videos
    • Webinars
    • National Whistleblower Day
  • Whistleblower Poll
  • Whistleblower Resources
    • Frequently Asked Questions
    • Resources for Locating An Attorney
    • The New Whistleblowers Handbook

Copyright © 2024, Whistleblower Network News. All Rights Reserved.

Go to mobile version